Starmab
Latest round
- Series A
Last raised
- Feb 2023
Total raised
- $15M
Investors
- 4
About Starmab
Based in Suzhou, China, and founded in 2020, Starmab operates as a developer of anti-infective macromolecules, focusing on the research and development of anti-infective macromolecules. The company is co-founded by Fosun Pharmaceuticals, Chongqing Yuyou Pharmaceuticals, Dr. Maomao An and Dr. Bohua Li. The company focuses on the development of anti-infective macromolecules, with 6 research and development pipelines. The pipelines involves gram-positive bacteria, gram-negative bacteria, fungi and viruses. Starmab has launched anti-MRSA bloodstream infection single domain antibody fusion protein XJ101 and Streptococcus pneumoniae neutralizing antibody XJ103, which can improve cure rates for severe MRSA and Streptococcus pneumoniae infections.licensing proprietary biologic technologies, securing strategic partnerships for clinical development, and monetizing milestone payments from pipeline advancements??.
Who invested in Starmab
4 investors across 1 round
See all investors in Starmab
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Feb 14, 2023
Amount
$15M
Investors
Questions about Starmab
Who invested in Starmab?
Starmab has 4 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Starmab raised?
Starmab has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Starmab last raise money?
Starmab's most recent round on record is a Series A, in Feb 2023.
What does Starmab do?
Based in Suzhou, China, and founded in 2020, Starmab operates as a developer of anti-infective macromolecules, focusing on the research and development of anti-infective macromolecules.
Where is Starmab headquartered?
Starmab is headquartered in Suzhou, China.
Which VCs invest in companies like Starmab?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Starmab's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Starmab? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.